Aptevo Therapeutics (APVO) Misses Q2 EPS by 840c

Aptevo Therapeutics (NASDAQ: APVO) reported Q2 EPS of ($8.40).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• Crude Inventory Rose 2.97 Million Barrels Last Week - EIA
• General Mills beats estimates as cost savings offset volumes
• Stitch Fix (SFIX) call put ratio 4.9 calls to 1 put with a focus on October 2.5 and 5 calls into quarter results